Novartis joins Pfizer in halting U.S. drug price hikes

Novartis expects to hit the top of its 2018 sales guidance after a strong second quarter, the CEO said, despite joining Pfizer in freezing its U.S. drug prices for the rest of the year following pressure from President Donald Trump.

from Reuters: Business News https://ift.tt/2uweCxi